| Schedule of Segment Loss, Including Significant Segment Expenses |
The table below is a summary of the segment loss, including significant segment expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
|
Six Months Ended June 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Revenues |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
Research and development expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
LTI-01 program-related expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
CMC activities |
|
|
89 |
|
|
|
247 |
|
|
|
156 |
|
|
|
784 |
|
Clinical operation activities |
|
|
119 |
|
|
|
216 |
|
|
|
119 |
|
|
|
281 |
|
Total LTI-01 program-related expenses |
|
|
208 |
|
|
|
463 |
|
|
|
275 |
|
|
|
1,065 |
|
LTI-03 program-related expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Preclinical study costs |
|
|
1 |
|
|
|
267 |
|
|
|
1 |
|
|
|
823 |
|
CMC activities |
|
|
744 |
|
|
|
836 |
|
|
|
1,264 |
|
|
|
1,396 |
|
Clinical operation activities |
|
|
2,094 |
|
|
|
2,162 |
|
|
|
4,055 |
|
|
|
2,835 |
|
Total LTI-03 program-related expenses |
|
|
2,839 |
|
|
|
3,265 |
|
|
|
5,320 |
|
|
|
5,054 |
|
Other program-related expenses |
|
|
42 |
|
|
|
1 |
|
|
|
42 |
|
|
|
9 |
|
Employee related expenses |
|
|
500 |
|
|
|
521 |
|
|
|
1,000 |
|
|
|
1,143 |
|
Professional fees for services |
|
|
— |
|
|
|
21 |
|
|
|
— |
|
|
|
38 |
|
Facilities and other expenses |
|
|
49 |
|
|
|
21 |
|
|
|
74 |
|
|
|
37 |
|
Total research and development expenses |
|
|
3,638 |
|
|
|
4,292 |
|
|
|
6,711 |
|
|
|
7,346 |
|
General and administrative expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Employee related expenses |
|
|
859 |
|
|
|
935 |
|
|
|
1,718 |
|
|
|
1,882 |
|
Professional fees for services |
|
|
1,070 |
|
|
|
1,036 |
|
|
|
1,860 |
|
|
|
2,174 |
|
Facilities and other expenses |
|
|
509 |
|
|
|
608 |
|
|
|
1,017 |
|
|
|
1,078 |
|
Total general and administrative expenses |
|
|
2,438 |
|
|
|
2,579 |
|
|
|
4,595 |
|
|
|
5,134 |
|
Other income |
|
|
162 |
|
|
|
60 |
|
|
|
178 |
|
|
|
182 |
|
Other expense |
|
|
(461 |
) |
|
|
(11 |
) |
|
|
(1,085 |
) |
|
|
(25 |
) |
Segment and consolidated net loss |
|
$ |
(6,375 |
) |
|
$ |
(6,822 |
) |
|
$ |
(12,213 |
) |
|
$ |
(12,323 |
) |
|